These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22456438)

  • 21. Significant increase of apolipoprotein B48 levels by a standard test meal in type 2 diabetic patients with nephropathy.
    Yamamoto T; Hirano T; Mori Y; Tokuno A; Nagashima M; Takada M; Morita R; Lee S; Hayashi T; Adachi M
    J Atheroscler Thromb; 2008 Aug; 15(4):199-205. PubMed ID: 18776703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of calcitriol on albuminuria in patients with type-2 diabetes mellitus.
    Bonakdaran S; Hami M; Hatefi A
    Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1215-20. PubMed ID: 23168851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
    Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
    Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiamine in diabetic nephropathy: a novel treatment modality?
    Alkhalaf A; Kleefstra N; Groenier KH; Bakker SJ; Navis GJ; Bilo HJ
    Diabetologia; 2009 Jun; 52(6):1212-3; author reply 1214-6. PubMed ID: 19296076
    [No Abstract]   [Full Text] [Related]  

  • 25. Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis.
    Meyer L; Chantrel F; Imhoff O; Sissoko A; Serb L; Dorey F; Fleury D; Smagala A; Kepenekian L; Krummel T; Le Floch JP; Kessler L
    Diabet Med; 2013 Nov; 30(11):1388-9. PubMed ID: 23909880
    [No Abstract]   [Full Text] [Related]  

  • 26. [Proteinuria in diabetic disease].
    Camici M; Iazzolino E; Evangelisti L
    Minerva Urol Nefrol; 1993 Dec; 45(4):127-30. PubMed ID: 8023221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
    Shahid SM; Nawab SN; Shaikh R; Mahboob T
    Pak J Pharm Sci; 2012 Jan; 25(1):123-9. PubMed ID: 22186319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease.
    Okada T; Nakao T; Matsumoto H; Nagaoka Y; Tomaru R; Iwasawa H; Wada T
    Intern Med; 2011; 50(1):23-9. PubMed ID: 21212569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal hemoglobin and the glycosylated hemoglobin assay.
    Grossman DM; Doyle GA; Hoeldtke RD
    Ann Intern Med; 1994 Mar; 120(6):524. PubMed ID: 7508701
    [No Abstract]   [Full Text] [Related]  

  • 30. The rise and fall of HbA(1c) as a risk marker for diabetes complications.
    Kilpatrick ES
    Diabetologia; 2012 Aug; 55(8):2089-91. PubMed ID: 22711013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients.
    Fu CC; Wu DA; Wang JH; Yang WC; Tseng CH
    Acta Diabetol; 2009 Jun; 46(2):127-34. PubMed ID: 18853099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
    Hirata K; Kubo K
    Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of cardiovascular risk factors and use of aspirin in diabetic patients remain elusive.
    Shrivastava R; Khan A; Jeevanantham V; Nautiyal A; Garg P; Reddy PC
    South Med J; 2008 Jun; 101(6):606-11. PubMed ID: 18475221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrapersonal HbA(1c) variability and the risk of progression of nephropathy in patients with Type 2 diabetes.
    Rodríguez-Segade S; Rodríguez J; García López JM; Casanueva FF; Camiña F
    Diabet Med; 2012 Dec; 29(12):1562-6. PubMed ID: 22913483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.
    Lin CC; Chen CC; Chen FN; Li CI; Liu CS; Lin WY; Yang SY; Lee CC; Li TC
    Am J Med; 2013 Nov; 126(11):1017.e1-10. PubMed ID: 23993260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
    Skrha J; Perusicová J; Pont'uch P; Oksa A
    Diabetes Res Clin Pract; 1997 Oct; 38(1):25-31. PubMed ID: 9347243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low serum endothelial cell-selective adhesion molecule predicts increase in albuminuria in type 2 diabetes patients.
    Kacso IM; Bondor CI; Kacso G
    Int Urol Nephrol; 2013 Oct; 45(5):1319-26. PubMed ID: 23292509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Not Available].
    Keller U
    Ther Umsch; 2017; 74(8):454-461. PubMed ID: 29461146
    [No Abstract]   [Full Text] [Related]  

  • 39. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.
    Wang N; Xu Z; Han P; Li T
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Albuminuria in patients with type 2 diabetes mellitus in relation to percentage of HbA1c].
    Kamińska J; Koper OM; Czyzewska J; Wasilewska K; Kemona H
    Pol Merkur Lekarski; 2012 May; 32(191):302-5. PubMed ID: 22779336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.